Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Department of Radiation Oncology, University of Washington, Seattle, Washington, USA.
J Appl Clin Med Phys. 2023 May;24(5):e13911. doi: 10.1002/acm2.13911. Epub 2023 Feb 7.
The purpose of this work is to assess the robustness of treatment plans when spot delivery errors were predicted with a machine learning (ML) model for intensity modulated proton therapy (IMPT). Over 6000 machine log files from delivered IMPT treatment plans were included in this study. From these log files, over 4.1 10 delivered proton spots were used to train the ML model. The presented model was tested and used to predict the spot position as well as the monitor units (MU) per spot, based on the original planning parameters. Two patient plans (one accelerated partial breast irradiation [APBI] and one ependymoma) were recalculated with the predicted spot position/MUs by the ML model and then were re-analyzed for robustness. Plans with ML predicted spots were less robust than the original clinical plans. In the APBI plan, dosimetric changes to the left lung and heart were not clinically relevant. In the ependymoma plan, the hot spot in the brainstem decreased and the hot spot in the cervical cord increased. Despite these differences, after robustness analysis, both ML spot delivery error plans resulted in >95% of the CTV receiving >95% of the prescription dose. The presented workflow has the potential benefit of including realistic spots information for plan quality checks in IMPT. This work demonstrates that in the two example plans, the plans were still robust when accounting for spot delivery errors as predicted by the ML model.
这项工作的目的是评估在机器学习(ML)模型预测强度调制质子治疗(IMPT)的点剂量误差时,治疗计划的稳健性。本研究纳入了超过 6000 份已交付的 IMPT 治疗计划的机器日志文件。从这些日志文件中,使用超过 4.1 10 个已交付的质子点来训练 ML 模型。所提出的模型经过测试,并用于根据原始计划参数预测点位置和每个点的监测单位(MU)。使用 ML 预测的点位置/MU 重新计算了两个患者计划(一个加速部分乳房照射[APBI]和一个室管膜瘤),然后对其稳健性进行重新分析。具有 ML 预测点的计划不如原始临床计划稳健。在 APBI 计划中,对左肺和心脏的剂量变化无临床意义。在室管膜瘤计划中,脑干的热点减少,颈髓的热点增加。尽管存在这些差异,但在稳健性分析后,两个 ML 点剂量误差计划均使超过 95%的CTV 接受超过 95%的处方剂量。所提出的工作流程具有将现实的点剂量信息纳入 IMPT 计划质量检查的潜在优势。这项工作表明,在这两个示例计划中,当考虑到 ML 模型预测的点剂量误差时,计划仍然具有稳健性。